Corcept Therapeutics logo

Vice President, Biology

Corcept Therapeutics

Redwood City, CAHybridPosted 39 days ago$340,000 - $375,000
Full TimeDirector & AboveResearch & ScientistPharmaceutical
Original posting ↗

Summary

This newly created role is an exciting opportunity to help shape and expand Corcept's internal scientific capabilities at a pivotal stage of growth. Reporting directly to the Chief Scientific Officer, the Vice President of Biology will lead a team of biologists, strengthen our internal research expertise, and help translate innovative science into the next generation of potential therapies.

Job description

With a broad portfolio of cortisol modulators moving through discovery and development, we are looking for a leader to own non-clinical biology end to end.

The Vice President of Biology sets non-clinical biology strategy, directs the discovery biology for our small-molecule pipeline, and serves as the scientific bridge between discovery and clinical development.

Corcept operates a lean, externally executed research model. The Vice President leads a small internal team and an external network of contract research organizations and academic collaborators.

This is a hybrid role based at our Redwood City, California headquarters, typically requiring on-site presence at least three days per week.

Responsibilities

  • Own non-clinical biology strategy across the portfolio and translate it into a research plan with defined deliverables, timelines, and budget
  • Serve as the CSO's primary partner on biology and as a senior internal authority on cortisol modulator pharmacology
  • Ensure the biology team has the expertise and capacity the growing portfolio requires, through internal development, new hires, or external partners
  • Direct the design of screening cascades for new cortisol modulators, including assay selection, with particular emphasis on oncology and neurology
  • Collaborate with clinical pharmacology on exposure-response, biomarker, and translational modeling questions
  • Oversee the planning, execution, and interpretation of in vitro and in vivo pharmacology studies supporting lead optimization, candidate selection, and IND-enabling work
  • Work with clinical development to understand clinical priorities and to design and advance the non-clinical studies required to support them
  • Serve as the scientific point of contact for translational scientists and ongoing non-clinical studies
  • Support medical affairs on scientific questions, data interpretation, and the accuracy of scientific communications
  • Author and approve non-clinical pharmacology sections of regulatory submissions, investigator brochures, briefing documents, and responses to health authority questions
  • Source, select, contract, and manage contract research vendors, including third-party staff; hold vendors to agreed quality and timelines; and allocate and oversee the non-clinical research budget
  • Manage existing academic collaborations as appropriate and identify new partnerships that could enhance Corcept's understanding of cortisol biology
  • Maintain a single view of the external research program so that findings from one collaborator reach the internal team and, where appropriate, other collaborators
  • Contribute to scientific publications and patents, and represent Corcept science externally

Preferred Skills, Qualifications and Technical Proficiencies

  • 15+ years in pharmaceutical or biotechnology non-clinical research, including at least five years leading a function, department, or major research group
  • Demonstrated record of advancing small molecules from lead optimization through candidate selection and into clinical development; this is a small-molecule company, and the role will not suit a candidate whose experience is predominantly in biologics
  • Direct oncology experience. Neurology, endocrinology, or metabolic disease experience is also an advantage
  • Ownership of screening cascade design in a discovery setting
  • Proven ability to plan and deliver a research program executed primarily through CROs, including vendor selection, contracting, and budget accountability
  • A record of hiring, developing, and retaining scientific staff to build and scale a research function
  • Ability to present complex non-clinical data to clinical, regulatory, and executive audiences, and to work effectively in a matrixed environment
  • Experience interacting with medical affairs and regulatory functions
  • Contribution to successful IND or NDA submissions in a non-clinical leadership capacity

Preferred Education and Experience

  • Ph.D. in biology, pharmacology, biochemistry, or a related discipline

Requirements

  • 15+ years in pharmaceutical or biotechnology non-clinical research
  • At least five years leading a function, department, or major research group
  • Demonstrated record of advancing small molecules from lead optimization through candidate selection and into clinical development
  • Direct oncology experience
  • Ownership of screening cascade design in a discovery setting
  • Proven ability to plan and deliver a research program executed primarily through CROs, including vendor selection, contracting, and budget accountability
  • A record of hiring, developing, and retaining scientific staff to build and scale a research function
  • Ability to present complex non-clinical data to clinical, regulatory, and executive audiences, and to work effectively in a matrixed environment
  • Experience interacting with medical affairs and regulatory functions
  • Contribution to successful IND or NDA submissions in a non-clinical leadership capacity
  • Ph.D. in biology, pharmacology, biochemistry, or a related discipline

Company overview

Corcept Therapeutics Inc. is a commercial-stage pharmaceutical company founded in 1998 and headquartered in Redwood City, California. The company specializes in the discovery, development, and commercialization of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effects of the hormone cortisol. Corcept's primary focus is on addressing the adverse effects of excess cortisol, which can lead to life-threatening conditions including Cushing's syndrome, various cancers, diabetes, and neurological disorders. The company's flagship product is Korlym (mifepristone), the first FDA-approved oral therapy for treating hyperglycemia in adult patients with endogenous Cushing's syndrome who have type 2 diabetes or glucose intolerance. With approximately 500 employees, Corcept has developed a large portfolio of proprietary compounds that selectively modulate cortisol effects without compromising progesterone function. The company maintains extensive intellectual property covering its selective cortisol modulators and continues to advance clinical trials for potential treatments of hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.